Next-Generation Systems Introduced for Clinical Laboratories

Several of the platforms will be designed to run more tests in less space, generate test results faster and minimize human errors. By offering a comprehensive solution that addresses the challenges of using multiple diagnostics platforms, while continuing to provide quality results that positively impact patient care, Alinity could potentially change the industry's testing paradigm.

Abbott expects Alinity launches to begin later this year and continue into 2017. The systems are supported by Abbott's AlinIQ, the first-of-its-kind, combined professional services and informatics solution that assists laboratories in achieving greater operational productivity with their existing resources. AlinIQ launched worldwide in April 2016. To develop each next-generation platform, Abbott's scientific and development teams engaged with thousands of clinicians, scientists, laboratory technicians and health care executives. The goal was to better understand their experiences and learn what is needed to address the challenges they face, whether in the core laboratory, at the point of care or in molecular diagnostics.

Dennis Gilbert, Ph.D., vice president at Abbott Diagnostics Products, said, “Abbott's Alinity systems are being built from the ground up based on customer insights, using the latest technologies suitable for testing today and in the future. Whether it's an easy-to-use software interface, running more tests faster or the ability to run any test at any time, our Alinity platforms are designed to include these features and more without any compromise in performance or quality.” The Alinity System was unveiled during the 68th AACC Annual Scientific Meeting & Clinical Lab Expo held July 31 to August 4, 2016, in Philadelphia, PA, USA.

Related Links:
Abbott Diagnostics
AACC Annual Scientific Meeting & Clinical Lab Expo